Home > 2017 ICD-10-CM Diagnosis Codes > Congenital malformations, deformations and chromosomal abnormalities Q00-Q99 > Other congenital malformations Q80-Q89 > Congenital malformation syndromes due to known exogenous causes, not elsewhere classified Q86-
2017 ICD-10-CM Diagnosis Code Q86.2
Dysmorphism due to warfarin
20162017Billable/Specific CodePOA Exempt
Q86.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
This is the American ICD-10-CM version of Q86.2. Other international versions of ICD-10 Q86.2 may differ.
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
A rare syndrome characterized by congenital abnormalities caused by fetal exposure to the administration of warfarin to the mother during pregnancy. The congenital abnormalities include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly.
Multiple abnormalities in infants whose mother were treated with coumarin anticoagulants during pregnancy. The most common anomalies include developmental delay, neurological complications (usually hydrocephalus and occasional agenesis of the corpus callosum and meningoencephalocele), midfacial hypoplasia, and various ocular, skeletal, and other defects.
Present On Admission
Q86.2 is considered exempt from POA reporting.
ICD-10-CM Q86.2 is grouped within Diagnostic Related Group (MS-DRG v34.0):